ARCHIVES

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Urged To Back Ultrasounds Studies

October 1, 1976

NIH Revises Application Receipt Dates

November 22, 1985

Army Accepting Letters of Intent For Research in Breast Cancer; Plans Announcement In Sept.

July 16, 1993

President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants

February 1, 1980

New CREG Announcements Made By NCI

October 3, 1975

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975